JANE STREET GROUP, LLC - INTRA CELLULAR THERAPIES INC ownership

Back to all holdings Add to watchlist

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q1 2023$779,760
-86.1%
14,400
-86.4%
0.00%
-100.0%
Q4 2022$5,620,104
+0.8%
106,200
-11.4%
0.00%
+50.0%
Q3 2022$5,574,000
-18.1%
119,800
+0.4%
0.00%
-33.3%
Q2 2022$6,810,000–119,300–0.00%–
 Download
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 38,400$1,787,0000.00%
SIMPLEX TRADING, LLC 36,200$1,684,0000.00%
JANE STREET GROUP, LLC 119,800$5,574,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders